Section Arrow
Quote
AVDL.NASDAQ
- Avadel Pharmaceuticals plc
Quotes are at least 15-min delayed:2024/11/10 17:01 EST
Last
 15.94
+0.22 (+1.40%)
Day High 
16.12 
Prev. Close
15.72 
1-M High
16.58 
Volume 
970.24K 
Bid
15.93
Ask
15.94
Day Low
15.63 
Open
15.72 
1-M Low
12.16 
Market Cap 
1.51B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.28 
20-SMA 13.82 
50-SMA 13.66 
52-W High 19.09 
52-W Low 10.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.09/1.03
Enterprise Value
1.52B
Balance Sheet
Book Value Per Share
0.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
27.96M
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.49-0.06-3.87%-- 
ESPREsperion Therapeutics2.275+0.165+7.82%-- 
VTRSViatris12.96-0.22-1.67%227.2PE
HLNHaleon plc9.61+0.01+0.10%31.1PE
CGCCanopy Growth Corp4.24-0.31-6.81%-- 
Quotes are at least 15-min delayed：2024/11/10 17:01 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.